| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromosomes, Human, Pair 3 | 11 | 2010 | 324 | 1.400 |
Why?
|
| Genes, Tumor Suppressor | 14 | 2013 | 1127 | 0.910 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2014 | 1901 | 0.820 |
Why?
|
| Ubiquitin-Protein Ligases | 6 | 2014 | 866 | 0.790 |
Why?
|
| Pancreatic Neoplasms | 15 | 2021 | 5257 | 0.580 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2022 | 1002 | 0.530 |
Why?
|
| Receptors, Endothelin | 2 | 2014 | 25 | 0.470 |
Why?
|
| Receptors, Angiotensin | 2 | 2014 | 45 | 0.470 |
Why?
|
| Parotid Neoplasms | 4 | 1999 | 150 | 0.470 |
Why?
|
| Chromosome Mapping | 19 | 1999 | 1647 | 0.440 |
Why?
|
| Cell Polarity | 1 | 2014 | 211 | 0.430 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2014 | 517 | 0.420 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 1385 | 0.400 |
Why?
|
| CA-19-9 Antigen | 3 | 2021 | 155 | 0.390 |
Why?
|
| Transforming Growth Factor beta | 2 | 2014 | 1104 | 0.380 |
Why?
|
| Carcinoma, Pancreatic Ductal | 7 | 2021 | 1830 | 0.370 |
Why?
|
| Adenoma, Islet Cell | 2 | 2002 | 25 | 0.360 |
Why?
|
| Tripartite Motif Proteins | 4 | 2014 | 46 | 0.340 |
Why?
|
| Breast | 2 | 2022 | 1370 | 0.330 |
Why?
|
| Biomarkers, Tumor | 8 | 2015 | 10713 | 0.320 |
Why?
|
| von Hippel-Lindau Disease | 2 | 2002 | 121 | 0.320 |
Why?
|
| Breast Neoplasms | 3 | 2022 | 16242 | 0.300 |
Why?
|
| Physical Chromosome Mapping | 1 | 2007 | 78 | 0.290 |
Why?
|
| Translocation, Genetic | 5 | 1999 | 1286 | 0.290 |
Why?
|
| Hybrid Cells | 23 | 2001 | 148 | 0.250 |
Why?
|
| Adenocarcinoma | 7 | 2011 | 7919 | 0.250 |
Why?
|
| Receptors, Immunologic | 1 | 2007 | 310 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2022 | 9047 | 0.240 |
Why?
|
| Proteins | 4 | 2013 | 2030 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2016 | 4642 | 0.220 |
Why?
|
| Ligases | 2 | 2002 | 81 | 0.210 |
Why?
|
| Cell Movement | 1 | 2010 | 2468 | 0.210 |
Why?
|
| Karyotyping | 12 | 1999 | 1064 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 4 | 6 | 1997 | 108 | 0.200 |
Why?
|
| Polymorphism, Genetic | 6 | 2008 | 1557 | 0.200 |
Why?
|
| MicroRNAs | 4 | 2021 | 2882 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 10 | 4 | 1996 | 142 | 0.190 |
Why?
|
| Ubiquitination | 2 | 2014 | 578 | 0.190 |
Why?
|
| Carcinoma, Renal Cell | 3 | 1999 | 2386 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 1581 | 0.180 |
Why?
|
| Epithelial Cells | 2 | 2022 | 1875 | 0.180 |
Why?
|
| Loss of Heterozygosity | 1 | 2002 | 623 | 0.170 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 1991 | 469 | 0.170 |
Why?
|
| Myoepithelioma | 1 | 1999 | 30 | 0.170 |
Why?
|
| Salivary Gland Neoplasms | 3 | 1999 | 497 | 0.170 |
Why?
|
| Adenoma, Pleomorphic | 1 | 1998 | 63 | 0.160 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 1998 | 84 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2010 | 300 | 0.150 |
Why?
|
| Protein Kinases | 2 | 1999 | 889 | 0.150 |
Why?
|
| Cell Fusion | 4 | 2000 | 77 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2010 | 538 | 0.150 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 14876 | 0.150 |
Why?
|
| Humans | 59 | 2022 | 270602 | 0.140 |
Why?
|
| Liver Neoplasms, Experimental | 4 | 1985 | 191 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2013 | 354 | 0.140 |
Why?
|
| Chromosome Aberrations | 3 | 1999 | 2035 | 0.130 |
Why?
|
| Animals | 37 | 2014 | 61346 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2011 | 230 | 0.130 |
Why?
|
| Culture Techniques | 1 | 1995 | 142 | 0.120 |
Why?
|
| Kidney Neoplasms | 2 | 1999 | 3107 | 0.120 |
Why?
|
| Cyst Fluid | 1 | 2014 | 21 | 0.120 |
Why?
|
| Mice | 29 | 2014 | 35413 | 0.120 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 1999 | 444 | 0.120 |
Why?
|
| Genes | 7 | 1992 | 604 | 0.110 |
Why?
|
| Mice, Nude | 9 | 2013 | 4332 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 10 | 2002 | 5759 | 0.110 |
Why?
|
| Pancreatic Cyst | 1 | 2014 | 111 | 0.110 |
Why?
|
| Female | 24 | 2022 | 148790 | 0.110 |
Why?
|
| Chromosome Banding | 4 | 1999 | 280 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 3582 | 0.110 |
Why?
|
| Snail Family Transcription Factors | 1 | 2013 | 119 | 0.110 |
Why?
|
| Smad3 Protein | 1 | 2013 | 121 | 0.110 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 1344 | 0.100 |
Why?
|
| Epithelium | 1 | 2014 | 786 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2014 | 2454 | 0.100 |
Why?
|
| Mitosis | 4 | 2008 | 681 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2022 | 4104 | 0.100 |
Why?
|
| MCF-7 Cells | 1 | 2013 | 547 | 0.100 |
Why?
|
| Genes, ras | 1 | 2014 | 678 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 10402 | 0.090 |
Why?
|
| RNA, Messenger | 5 | 2014 | 6344 | 0.090 |
Why?
|
| Tenascin | 1 | 2010 | 50 | 0.090 |
Why?
|
| Genetic Markers | 6 | 2007 | 1073 | 0.090 |
Why?
|
| Subtraction Technique | 1 | 2010 | 143 | 0.090 |
Why?
|
| Carcinoma, Mucoepidermoid | 3 | 1996 | 141 | 0.090 |
Why?
|
| Carcinoma | 2 | 2000 | 2610 | 0.090 |
Why?
|
| Microsatellite Repeats | 4 | 2000 | 627 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2016 | 1034 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2013 | 1683 | 0.090 |
Why?
|
| Gene Dosage | 2 | 2016 | 822 | 0.090 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2002 | 163 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2008 | 744 | 0.080 |
Why?
|
| Muscle Neoplasms | 1 | 2010 | 108 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2010 | 229 | 0.080 |
Why?
|
| Male | 24 | 2021 | 128395 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1458 | 0.080 |
Why?
|
| Ovary | 1 | 2013 | 686 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2013 | 5415 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 1998 | 2312 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 5157 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2013 | 3568 | 0.080 |
Why?
|
| Tyrosine Transaminase | 2 | 1985 | 18 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2008 | 506 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 2478 | 0.080 |
Why?
|
| Lymphatic Metastasis | 1 | 1998 | 4969 | 0.080 |
Why?
|
| Embryo Loss | 1 | 2008 | 39 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2008 | 62 | 0.080 |
Why?
|
| Cell Line | 9 | 1995 | 5313 | 0.080 |
Why?
|
| Morphogenesis | 1 | 2009 | 316 | 0.070 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 198 | 0.070 |
Why?
|
| Spindle Apparatus | 1 | 2008 | 113 | 0.070 |
Why?
|
| Prostatic Neoplasms | 4 | 2001 | 5869 | 0.070 |
Why?
|
| Sequence Tagged Sites | 1 | 2007 | 43 | 0.070 |
Why?
|
| Prognosis | 5 | 2013 | 22520 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 1503 | 0.070 |
Why?
|
| Clone Cells | 5 | 2013 | 589 | 0.070 |
Why?
|
| Genetic Variation | 3 | 2010 | 2157 | 0.070 |
Why?
|
| Neoplasm Proteins | 5 | 2008 | 3345 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 9 | 2008 | 3464 | 0.070 |
Why?
|
| Genotype | 6 | 2016 | 4246 | 0.070 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 1986 | 28 | 0.070 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1986 | 25 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 1999 | 381 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1992 | 290 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 4053 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 1072 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 366 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2014 | 12042 | 0.060 |
Why?
|
| Pedigree | 2 | 2002 | 2040 | 0.060 |
Why?
|
| Genetic Complementation Test | 3 | 1999 | 146 | 0.060 |
Why?
|
| Base Sequence | 8 | 1995 | 5405 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 1999 | 275 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 2358 | 0.060 |
Why?
|
| Flow Cytometry | 4 | 1999 | 3040 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2008 | 525 | 0.060 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1984 | 31 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2013 | 5144 | 0.060 |
Why?
|
| Middle Aged | 14 | 2021 | 90450 | 0.060 |
Why?
|
| Molecular Sequence Data | 7 | 1995 | 6639 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 1276 | 0.060 |
Why?
|
| Pancreas | 2 | 2021 | 737 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 2 | 2002 | 1586 | 0.060 |
Why?
|
| Cell Division | 4 | 2001 | 2657 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2009 | 2087 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 1704 | 0.060 |
Why?
|
| Neoplasm Metastasis | 4 | 2010 | 5318 | 0.050 |
Why?
|
| Thymidine Kinase | 1 | 1984 | 223 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 1250 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 2051 | 0.050 |
Why?
|
| Carcinoma, Small Cell | 2 | 1996 | 426 | 0.050 |
Why?
|
| Isoenzymes | 1 | 1984 | 644 | 0.050 |
Why?
|
| Ovarian Neoplasms | 2 | 2013 | 4800 | 0.050 |
Why?
|
| Apoptosis | 1 | 1996 | 7755 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 4 | 1997 | 273 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2021 | 6234 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 2001 | 800 | 0.050 |
Why?
|
| Ploidies | 2 | 2002 | 250 | 0.050 |
Why?
|
| Aged | 11 | 2021 | 73534 | 0.040 |
Why?
|
| Blood Specimen Collection | 1 | 2021 | 96 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2021 | 178 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2021 | 2360 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2001 | 190 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2000 | 183 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 1195 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 1996 | 413 | 0.040 |
Why?
|
| DNA, Neoplasm | 3 | 2010 | 1958 | 0.040 |
Why?
|
| Desmin | 1 | 1999 | 61 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2001 | 1553 | 0.040 |
Why?
|
| Lung Neoplasms | 4 | 2014 | 12038 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1999 | 150 | 0.040 |
Why?
|
| Chemokines, CXC | 2 | 1989 | 124 | 0.040 |
Why?
|
| Fibroblasts | 5 | 1995 | 1647 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 31084 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1999 | 197 | 0.040 |
Why?
|
| Keratins | 1 | 1999 | 340 | 0.040 |
Why?
|
| Cell Survival | 4 | 1993 | 3058 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1999 | 298 | 0.040 |
Why?
|
| Chromosome Inversion | 1 | 1999 | 197 | 0.040 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1998 | 192 | 0.040 |
Why?
|
| Adult | 7 | 2021 | 81960 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1999 | 203 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 1999 | 7643 | 0.040 |
Why?
|
| Chromosomes, Human | 2 | 1987 | 288 | 0.040 |
Why?
|
| Demecolcine | 2 | 1995 | 20 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 1996 | 666 | 0.040 |
Why?
|
| Rats | 7 | 1996 | 6396 | 0.040 |
Why?
|
| Cell Nucleus | 3 | 1995 | 1715 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2010 | 2434 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2011 | 1246 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 5581 | 0.040 |
Why?
|
| Aurora Kinases | 2 | 2008 | 193 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 3435 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 10267 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2013 | 5658 | 0.030 |
Why?
|
| Haplotypes | 2 | 2011 | 908 | 0.030 |
Why?
|
| Actins | 1 | 1999 | 586 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2002 | 1196 | 0.030 |
Why?
|
| DNA Damage | 2 | 1996 | 1991 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 1989 | 659 | 0.030 |
Why?
|
| MyoD Protein | 1 | 1995 | 32 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2016 | 246 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1996 | 155 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 4992 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 1999 | 566 | 0.030 |
Why?
|
| Blotting, Southern | 5 | 1997 | 453 | 0.030 |
Why?
|
| Concanavalin A | 1 | 1995 | 63 | 0.030 |
Why?
|
| Mutation | 3 | 2014 | 15905 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 1995 | 142 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 5776 | 0.030 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 1995 | 32 | 0.030 |
Why?
|
| Neoplasms, Experimental | 2 | 2002 | 784 | 0.030 |
Why?
|
| Point Mutation | 1 | 1998 | 785 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1995 | 137 | 0.030 |
Why?
|
| Pheochromocytoma | 1 | 1998 | 310 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 380 | 0.030 |
Why?
|
| Liver | 1 | 1984 | 3056 | 0.030 |
Why?
|
| DNA Primers | 3 | 2008 | 1489 | 0.030 |
Why?
|
| Pancreatitis, Chronic | 1 | 2015 | 127 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 1995 | 154 | 0.030 |
Why?
|
| Cricetinae | 6 | 1992 | 744 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1995 | 697 | 0.030 |
Why?
|
| Gene Deletion | 1 | 1999 | 1471 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2010 | 39922 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 908 | 0.030 |
Why?
|
| Phenotype | 4 | 2013 | 6501 | 0.030 |
Why?
|
| Trisomy | 1 | 1994 | 240 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 2419 | 0.030 |
Why?
|
| Adenine Phosphoribosyltransferase | 1 | 1992 | 7 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1992 | 45 | 0.030 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1998 | 527 | 0.030 |
Why?
|
| Tretinoin | 1 | 1995 | 632 | 0.030 |
Why?
|
| Chromosomes, Fungal | 1 | 1992 | 55 | 0.030 |
Why?
|
| Luciferases | 1 | 2013 | 454 | 0.030 |
Why?
|
| Binding Sites | 1 | 2016 | 2249 | 0.020 |
Why?
|
| Sarcoma | 1 | 2002 | 1851 | 0.020 |
Why?
|
| Risk Factors | 3 | 2016 | 17855 | 0.020 |
Why?
|
| Cell Death | 1 | 1994 | 686 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 1992 | 124 | 0.020 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 1992 | 125 | 0.020 |
Why?
|
| Smoking | 2 | 2011 | 2549 | 0.020 |
Why?
|
| Chromosomes | 2 | 1989 | 325 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2014 | 442 | 0.020 |
Why?
|
| Alleles | 2 | 2010 | 2597 | 0.020 |
Why?
|
| Transformation, Genetic | 1 | 1980 | 66 | 0.020 |
Why?
|
| Gene Expression | 2 | 1996 | 3606 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 503 | 0.020 |
Why?
|
| Decision Making | 1 | 1998 | 1249 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 676 | 0.020 |
Why?
|
| Recurrence | 1 | 1999 | 4878 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 494 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 205 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1992 | 1407 | 0.020 |
Why?
|
| Young Adult | 2 | 2021 | 22219 | 0.020 |
Why?
|
| Computational Biology | 1 | 2016 | 1295 | 0.020 |
Why?
|
| Age Factors | 2 | 2011 | 5441 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 1980 | 151 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 1989 | 51 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 1825 | 0.020 |
Why?
|
| Skin | 1 | 1995 | 1281 | 0.020 |
Why?
|
| Platelet Factor 4 | 1 | 1989 | 37 | 0.020 |
Why?
|
| Tumor Protein p73 | 1 | 2008 | 114 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2013 | 1825 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 1991 | 542 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1993 | 1048 | 0.020 |
Why?
|
| Colony-Stimulating Factors | 1 | 1988 | 83 | 0.020 |
Why?
|
| Morula | 1 | 2008 | 4 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 1988 | 110 | 0.020 |
Why?
|
| Retinoblastoma | 1 | 1989 | 189 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1991 | 628 | 0.020 |
Why?
|
| Disease Progression | 2 | 2009 | 6867 | 0.020 |
Why?
|
| G2 Phase | 1 | 2008 | 218 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1987 | 136 | 0.020 |
Why?
|
| Hexosaminidase B | 1 | 1986 | 2 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 1307 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 1562 | 0.020 |
Why?
|
| Aurora Kinase A | 1 | 2008 | 209 | 0.020 |
Why?
|
| Retroviridae | 1 | 1987 | 372 | 0.020 |
Why?
|
| Glioma | 1 | 1997 | 1986 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1987 | 161 | 0.020 |
Why?
|
| Age of Onset | 1 | 2008 | 853 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 1987 | 240 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2007 | 315 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 573 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 14021 | 0.020 |
Why?
|
| Genomics | 1 | 2016 | 2832 | 0.020 |
Why?
|
| Salivary Glands, Minor | 2 | 1996 | 36 | 0.020 |
Why?
|
| Propanols | 1 | 1984 | 1 | 0.020 |
Why?
|
| 1-Propanol | 1 | 1984 | 2 | 0.020 |
Why?
|
| Pentanols | 1 | 1984 | 2 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 1984 | 34 | 0.020 |
Why?
|
| Alcohols | 1 | 1984 | 24 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 2300 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 1101 | 0.010 |
Why?
|
| Bisbenzimidazole | 1 | 1984 | 8 | 0.010 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2008 | 703 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1984 | 128 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1987 | 764 | 0.010 |
Why?
|
| Culture Media | 1 | 1984 | 340 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 9460 | 0.010 |
Why?
|
| Cell Count | 1 | 1984 | 509 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2010 | 1535 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1984 | 579 | 0.010 |
Why?
|
| Kinetics | 1 | 1986 | 2206 | 0.010 |
Why?
|
| DNA | 4 | 1997 | 3042 | 0.010 |
Why?
|
| Cricetulus | 3 | 1989 | 214 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2008 | 2272 | 0.010 |
Why?
|
| Lung | 1 | 2014 | 3284 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 7050 | 0.010 |
Why?
|
| Deoxycytidine | 1 | 2008 | 1389 | 0.010 |
Why?
|
| Light | 1 | 1984 | 279 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 1930 | 0.010 |
Why?
|
| Glioblastoma | 1 | 1993 | 1776 | 0.010 |
Why?
|
| Insulin | 1 | 1988 | 1425 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 2346 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 246 | 0.010 |
Why?
|
| Cell Separation | 1 | 1984 | 606 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2002 | 242 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 231 | 0.010 |
Why?
|
| Lymphokines | 1 | 2002 | 313 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 4964 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6257 | 0.010 |
Why?
|
| Agar | 1 | 2001 | 26 | 0.010 |
Why?
|
| Cisplatin | 1 | 2008 | 2499 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 2000 | 70 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2008 | 4006 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1998 | 4837 | 0.010 |
Why?
|
| Genetic Linkage | 2 | 1996 | 603 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2013 | 7232 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 5099 | 0.010 |
Why?
|
| Chemokine CXCL1 | 2 | 1989 | 67 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2010 | 9281 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 573 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2008 | 5692 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1997 | 230 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 9041 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 153 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 1985 | 4105 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 1996 | 143 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1996 | 53 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2002 | 1580 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1997 | 440 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 1995 | 44 | 0.010 |
Why?
|
| Carcinoma, Embryonal | 1 | 1995 | 31 | 0.010 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 1995 | 94 | 0.010 |
Why?
|
| Wnt1 Protein | 1 | 1995 | 100 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12527 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2008 | 5238 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 12971 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1996 | 329 | 0.010 |
Why?
|
| Species Specificity | 1 | 1996 | 783 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1995 | 367 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 1995 | 14638 | 0.010 |
Why?
|
| Extremities | 1 | 1995 | 311 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 1995 | 383 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1995 | 489 | 0.010 |
Why?
|
| Genomic Library | 1 | 1992 | 58 | 0.010 |
Why?
|
| Transfection | 1 | 1997 | 3109 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1996 | 459 | 0.010 |
Why?
|
| Annexin A3 | 1 | 1991 | 1 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1992 | 253 | 0.010 |
Why?
|
| Mitoxantrone | 1 | 1992 | 227 | 0.010 |
Why?
|
| CHO Cells | 1 | 1992 | 320 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1993 | 1051 | 0.010 |
Why?
|
| Galactokinase | 1 | 1980 | 5 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 1980 | 15 | 0.010 |
Why?
|
| Homozygote | 1 | 1993 | 771 | 0.010 |
Why?
|
| Daunorubicin | 1 | 1992 | 313 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1991 | 356 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1991 | 239 | 0.010 |
Why?
|
| Introns | 1 | 1991 | 460 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 2986 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1992 | 649 | 0.010 |
Why?
|
| Penis | 1 | 1980 | 143 | 0.010 |
Why?
|
| Etoposide | 1 | 1992 | 907 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1995 | 1491 | 0.010 |
Why?
|
| Muridae | 1 | 1989 | 23 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1996 | 2561 | 0.010 |
Why?
|
| DNA Probes | 1 | 1989 | 244 | 0.000 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1995 | 1837 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 161 | 0.000 |
Why?
|
| Metaphase | 1 | 1987 | 124 | 0.000 |
Why?
|
| Sarcoma 180 | 1 | 1987 | 5 | 0.000 |
Why?
|
| Phosphonoacetic Acid | 1 | 1987 | 19 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 3328 | 0.000 |
Why?
|
| Aspartic Acid | 1 | 1987 | 136 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 16719 | 0.000 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 2618 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1987 | 608 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1992 | 3145 | 0.000 |
Why?
|
| Adolescent | 1 | 1996 | 32684 | 0.000 |
Why?
|